Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
Public ClinicalTrials.gov record NCT05644262. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Life's End Benefits of cannaBidiol and tetrahYdrocannabinol (LiBBY)
Study identification
- NCT ID
- NCT05644262
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of Southern California
- Other
- Enrollment
- 120 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 17, 2023
- Primary completion
- Apr 29, 2026
- Completion
- Jul 31, 2026
- Last update posted
- May 3, 2026
2023 – 2026
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Georgetown University | Washington D.C. | District of Columbia | 20007 | — |
| Howard University | Washington D.C. | District of Columbia | 20059 | — |
| Melgar-Caro Medcenter and Community Research (MCMCR) | Miami | Florida | 33145 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| University of Kentucky | Lexington | Kentucky | 40504 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Case Western Reserve University | Beachwood | Ohio | 44122 | — |
| Ralph H. Johnson VA Medical Center | Charleston | South Carolina | 29401 | — |
| Vanderbilt University Medical Center Center for Cognitive Medicine | Nashville | Tennessee | 37212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05644262, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2026 · Synced May 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05644262 live on ClinicalTrials.gov.